Table 3.
Characteristics of studies included in meta‐analysis (correlation of Yes‐associated protein [YAP] expression in hepatocellular carcinoma with clinicopathological features)
| Study | YAP (+) | YAP (+) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Sex (M/F) | Vascular invasion (Y) | Cellular differentiation (L) | Tumour Size (>5 cm) | TNM (I + II) | AFP (>400 ng/mL) | Tumour Number (>1) | Hepatitis (Y/N) | AJCC (I) | ||
| Lei (2015) | 42 | 38/4 | 25 | N | N | N | 40 | N | N | 17 |
| Li (2015)25 | 54 | 49/5 | 31 | 8 | 33 | N | 29 | 29 | 52 | 10 |
| Han (2014)5 | 27 | 25/2 | 3 | 12 | 15 | 10 | N | 1 | 23 | N |
| Xu (2009)11 | 110 | 90/20 | 59 | 21 | N | N | 57 | 24 | 69 | 42 |
| Wu (2016)23 | 78 | 67/11 | 28 | N | 61 | 19 | N | N | 74 | N |
| Wang (2016)7 | 59 | 56/3 | 11 | 30 | N | N | N | 35 | 55 | N |
| Xu (2013)9 | 129 | 108/21 | 57 | 47 | 65 | 88 | N | 21 | 126 | N |
| Liu (2015)12 | 49 | N | 33 | 15 | N | 32 | 43 | N | N | N |